🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary trial objective in this single arm trial is to assess the safety an...
Status
Completed
Location
Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital
Start Date
2009-04
Trial ID
NCT00879866
Treatments Being Tested
The purpose of this study is to compare the free time to disease progressio...
Status
Completed
Location
Spanish Cooperative Group for Gastrointestinal Tumour Therapy
Start Date
2006-07
Trial ID
NCT00335595
The overall aim of the study is to establish bioequivalence between commerc...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-05
Trial ID
NCT01599377
Treatments Being Tested
The study aims to investigate the underlying mechanism between Attention De...
Status
Completed
Location
The University of Hong Kong
Start Date
2023-12-28
Trial ID
NCT06352801
Treatments Being Tested
This phase I trial studies the side effects and best dose of AR-42 when giv...
Status
Completed
Location
Cincinnati Children's Hospital
Start Date
2013-09-17
Trial ID
NCT01798901
Treatments Being Tested
A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Sin...
Status
Completed
Location
The First Hospital of Jilin University
Start Date
2019-03-06
Trial ID
NCT03903081
Treatments Being Tested
This study is to evaluate the safety, tolerability and immunogenicity of a ...
Status
Completed
Location
Daido Clinic
Start Date
2018-07-12
Trial ID
NCT03571607
Treatments Being Tested
RATIONALE: Providing information that is tailored to answer patients' quest...
Status
Completed
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2008-04
Trial ID
NCT00750009
Treatments Being Tested
Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-01-01
Trial ID
NCT04767009
Treatments Being Tested
This Phase IIB, multicenter, double-blind, randomized, and uncontrolled cli...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05
Trial ID
NCT06905834